We determined gene expression in nine cancerous and tumor- adjacent tissues from patients with GBM and found that expression levels of FMOD, MXRA5, and RAB36 in the cancer tissue was higher than those in the para-cancerous tissue in most patients (Figure 4D-F). The gene discussed is MXRA5; the disease is glioblastoma.